Bio/Pharma News

May 23, 2014
By Pharmaceutical Technology Editors
GE Healthcare launches the Xuri IL-2 for the activation and expansion of T-lymphocytes.
May 22, 2014
By Pharmaceutical Technology Editors
Cytovance Biologics and Selexys Pharmaceuticals enter an agreement for development of clinical trial materials.
May 22, 2014
By Pharmaceutical Technology Editors
Merck KGaA fill-finish expansion in Italy will be completed in 2017.
May 21, 2014
By Pharmaceutical Technology Editors
BMS and AbbVie receive FDA breakthrough therapy designation for elotuzumab, an investigational humanized monoclonal antibody for multiple myeloma.
May 21, 2014
By Pharmaceutical Technology Editors
Pfizer will submit a NDA with FDA for palbociclib, a treatment for locally advanced or metastatic breast cancer.
May 20, 2014
By Pharmaceutical Technology Editors
FDA issues complete response letter for Novartis' RLX030 for acute heart failure.
May 20, 2014
By Pharmaceutical Technology Editors
Novartis settles its litigation with the US subsidiary of Sun Pharma regarding Gleevec.
May 19, 2014
By Pharmaceutical Technology Editors
AstraZeneca rejects Pfizer's final offer of $118 billion for a proposed merger of the two companies.
May 15, 2014
By Pharmaceutical Technology Editors
AstraZeneca will collaborate with the Medical Research Council Laboratory of Molecular Biology to fund a range of pre-clinical research projects.
May 15, 2014
By Pharmaceutical Technology Editors
Santen will purchase Merck's ophthalmology products business in Japan and key markets in Europe and Asia Pacific.
native1_300x100
lorem ipsum